|
||
|
Venture capital firms and funds in Europe 128 Venture Capital Group 3i Venture Capital Accuitive Medical Acer Venture Capital Act Venture Capital Ltd Adelaide Venture Capital Email ADS Ventures Boston Advantages Of Venture Capital Advent Venture Capital Agio Capital Alabama Venture Capital Alaska Venture Capital All Stages Venture Capital American Venture Capital Analysis Venture Capital Analyze Venture Capital Angel Capital Appraisal Venture Capital Arch Venture Capital Argentina Venture Capital Arizona Venture Capital Arkansas Venture Capital Arrowpath Venture Capital Assess Venture Capital Assessment Venture Capital Atlas Venture Capital ATV Venture Capital Aurora Fund Australia Venture Capital Austria Venture Capital Automotive Venture Capital AZ Venture Capital VCgate More Venture Capital Terms and Topics
-
Anthera Pharmaceuticals Secures $36 Million in Venture Capital Financing
September 14th, 2006 No comments
Anthera Pharmaceuticals‚ a specialty pharmaceutical company developing therapies for the treatment of serious inflammatory diseases‚ recently announced it closed an initial $36 Million in venture financing. The funding was co–led by VantagePoint Venture Partners and Sofinnova Ventures and are joined by Pappas Ventures‚ Mitsubishi International Corporation‚ along with Series A–1 investors Sears Capital Management and SIM Equity. Eli Lilly and Company and Shionogi & Co.‚ Ltd. also received equity as part of Anthera’s obligations under the recently announced license agreement. Annette Bianchi‚ Managing Director‚ and co–Head of VantagePoint’s Healthcare Practice Group and Jim Healy‚ General Partner of Sofinnova Ventures were named to the Board of Directors.
The funding will be used to initiate clinical development of Anthera’s portfolio of anti–inflammatory compounds licensed from Eli Lilly and Company and Shionogi & Co.‚ Ltd. The Company’s research programs are preparing for Phase II clinical testing in multiple indications. Anthera will initiate clinical studies later this year for the program’s lead compound A–001 as an early intervention therapy for acute chest syndrome in patients with underlying sickle cell disease – a $500 Million worldwide market opportunity.
“We are pleased to have the support of a strong group of investors that share our confidence and excitement in the promise of this unique class of anti–inflammatory compounds‚” said Paul F. Truex‚ President and Chief Executive Officer of Anthera. “Anthera will benefit from the experience and commitment of our new investors and the management team and I look forward to partnering with them to pursue additional opportunities to enhance our portfolio.”
“Anthera is well positioned to build an attractive portfolio and leverage the commercial potential of sPLA2‚ inhibitors in multiple indications”‚ said Annette Bianchi‚ VantagePoint Venture Partners. “We look forward to working toward this goal with our co–investors and the talented management team of Anthera.
“Anthera is a compelling company for Sofinnova because it falls into our investment sweet spot‚” commented Sofinnova Ventures General Partner Jim Healy‚ M.D.‚ Ph.D.. “With a first rate management team and a promising drug pipeline spun off from big pharma‚ it has the same poise for success that we have experienced with some of its predecessors in the pulmonary space‚ such as Actelion‚ Intermune and CoTherix.
Leave a reply
Latest Headlines:
Friday August 31, 2012
Zscaler Secures $38 Million Investment Round
Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.
Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects
Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding
Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies
Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains
Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster
Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility